ABERCROMBIE & FITCH ($ANF) is expected to release its quarterly earnings data on Monday, November 24th before market open, per Finnhub. Analysts are expecting revenue of $1,296,570,107 and earnings of $2.19 per share.
You can see Quiver Quantitative's $ANF stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ABERCROMBIE & FITCH Insider Trading Activity
ABERCROMBIE & FITCH insiders have traded $ANF stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ANF stock by insiders over the last 6 months:
- JAMES A GOLDMAN sold 5,072 shares for an estimated $487,824
- KERRII B ANDERSON sold 4,292 shares for an estimated $408,234
- JAY RUST (EVP Human Resources) sold 1,500 shares for an estimated $139,725
- KENNETH B. ROBINSON sold 1,392 shares for an estimated $131,683
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ABERCROMBIE & FITCH Hedge Fund Activity
We have seen 198 institutional investors add shares of ABERCROMBIE & FITCH stock to their portfolio, and 277 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 1,173,601 shares (+5749.6%) to their portfolio in Q3 2025, for an estimated $100,401,565
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 562,421 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $46,596,579
- BOSTON PARTNERS added 553,889 shares (+102.5%) to their portfolio in Q3 2025, for an estimated $47,385,203
- FMR LLC removed 548,191 shares (-16.7%) from their portfolio in Q3 2025, for an estimated $46,897,740
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 505,574 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $43,251,855
- BALYASNY ASSET MANAGEMENT L.P. added 451,307 shares (+1439.4%) to their portfolio in Q3 2025, for an estimated $38,609,313
- JUNTO CAPITAL MANAGEMENT LP removed 434,977 shares (-63.2%) from their portfolio in Q3 2025, for an estimated $37,212,282
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ABERCROMBIE & FITCH Analyst Ratings
Wall Street analysts have issued reports on $ANF in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/19/2025
- Telsey Advisory Group issued a "Outperform" rating on 11/18/2025
- Jefferies issued a "Buy" rating on 11/14/2025
- UBS issued a "Buy" rating on 11/13/2025
- Raymond James issued a "Outperform" rating on 05/29/2025
To track analyst ratings and price targets for ABERCROMBIE & FITCH, check out Quiver Quantitative's $ANF forecast page.
ABERCROMBIE & FITCH Price Targets
Multiple analysts have issued price targets for $ANF recently. We have seen 9 analysts offer price targets for $ANF in the last 6 months, with a median target of $99.0.
Here are some recent targets:
- Janine Stichter from BTIG set a target price of $118.0 on 11/19/2025
- Dana Telsey from Telsey Advisory Group set a target price of $125.0 on 11/18/2025
- Corey Tarlowe from Jefferies set a target price of $100.0 on 11/14/2025
- Mauricio Serna from UBS set a target price of $125.0 on 11/13/2025
- Paul Lejuez from Citigroup set a target price of $79.0 on 11/04/2025
- Matthew Boss from JP Morgan set a target price of $92.0 on 10/27/2025
- Rick Patel from Raymond James set a target price of $99.0 on 05/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.